BioVendor

BioVendor Group operates as a multinational biotechnology firm specializing in in-vitro diagnostic (IVD) products. Founded in 1992 by Czech physician Viktor Růžička, the company began as a small distribution business in a family villa and has since grown into a significant player in the global diagnostics market. The founder's vision was to introduce products that advance the field of diagnostics and provide substantial benefits to patients. A few years after its founding, the company began developing its own diagnostic kits, laying the foundation for what is now BioVendor R&D.

The company's growth has been fueled by both organic expansion and a series of strategic acquisitions, including TestLine Clinical Diagnostics, ViennaLab Diagnostics, Oxford Biosystems, and DIAsource ImmunoAssays. This has broadened its portfolio and expanded its international presence to over 115 countries. In 2017, the company was acquired by Consillium, the family office of Czech businessman Tomáš Němec. More recently, in March 2025, the global private equity healthcare specialist ARCHIMED acquired BioVendor Group, aiming to further accelerate its growth through internationalization and product range expansion.

BioVendor develops, manufactures, and distributes a wide array of products and technologies for laboratory diagnostics. Its business model encompasses direct sales and a worldwide network of distribution partners, serving clinical customers and the life sciences research community. The product portfolio is extensive, covering clinical biochemistry, immunology, hematology, microbiology, and molecular biology. Key product categories include immunoassays (ELISA, CLIA, RIA), recombinant proteins, antibodies, and molecular diagnostic tools like Next-Generation Sequencing (NGS), LAMP, and miRNA-based tests. The firm has also developed proprietary solutions such as the Microblot-Array, a multiplex immunoblot test, and a fully automated CLIA solution for diagnostic laboratories.

Keywords: in-vitro diagnostics, immunoassay development, molecular diagnostics, ELISA kits, diagnostic reagents, recombinant proteins, monoclonal antibodies, laboratory automation, Next-Generation Sequencing (NGS), CLIA, miRNA, LAMP tests, autoimmune diseases diagnostics, infectious diseases serology, endocrinology testing, genetic testing, IVD products, clinical diagnostics, life sciences research, multiplex testing